SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: Manfred who wrote (5281)6/9/1999 6:19:00 PM
From: CatLady  Read Replies (1) | Respond to of 5736
 
This isn't "new" news, it's expected news. Long expected.

Checkout the BTIM chart on April 1, when they got FDA approval.

P.S. I also haven't seen any "newbees" hanging out here, it's the same old crowd as last year.




To: Manfred who wrote (5281)6/9/1999 6:23:00 PM
From: Peter V  Read Replies (2) | Respond to of 5736
 
Manfred, I don't care what you do. I'm not desperate, I don't even have a position. I haven't lost anything.

Institutions? Give me a break. CCSI doesn't manufacture or distribute this product, and the distributor must overcome a lot of inertia (heel sticks have been used for decades and are very inexpensive) to achieve significant market penetration. CCSI's revenues from this product are likely to be very low for the coming year, at least.

Try to add some substance to the conversation. Your dire predictions are tiresome.



To: Manfred who wrote (5281)6/10/1999 12:12:00 PM
From: Marconi  Read Replies (1) | Respond to of 5736
 
Hello Manfred:
News for story stocks that are not going concerns generally brings pricing closer to reality. News removes a layer of mystique moving the concern closer to fundamentals. I looked over the domestic Ohmeda site. I found nothing about CCSI. Ohmeda is in the capnography and gas delivery business solidly, and in critical care settings. BTW oximetry is a fluke business that came about from a lawsuit long ago. The nicety of avoiding stick to neonates is hardly critical care. My impression is the CCSI announcement does not mean much. Who would give up much of their bread and butter to push an overpriced nicety when you can sell required hardware for the clear cut case of critical care medicine? Come to greater reason, Manfred.
Regards,
m